What is the clinical effectiveness of hydrotherapy in maintaining physical function in people with Duchenne muscular dystrophy?

Not Applicable

Completed

• Conditions: Topic: Children, Genetics; Subtopic: All Diagnoses, Genetics Research and Congenital Disorders (all subtopics); Disease: Genetics Research and Congenital Disorders, All Diseases; Nervous System Diseases; Muscular dystrophy

• Registration Number: ISRCTN41002956
• Lead Sponsor: Sheffield Children's Hospital (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-06-12
• Last Update Posted: 24 April 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

1. Genetically or biopsy confirmed DMD
2. Age 7-16 years
3. Established on glucocorticosteroids
4. North Star Ambulatory Assessment score 8-34 (stable over 4 weeks)
5. Able to complete 10 metre walk (6 minute walk test)

Exclusion Criteria

1.More than a 20% variation between baseline North Star Ambulatory Assessment scores
2.Unable to commit to the programme of twice weekly hydrotherapy for 6 months
3.Any absolute contraindications or precautions to hydrotherapy

Study & Design

• Study Type: Interventional
• Study Design: Not specified